JD HEALTH
06618
BIDU-SW
09888
JD-SW
09618
ALI HEALTH
00241
BEKE-W
02423
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 16.75%6.11B | -0.30%10.32B | -1.23%5.24B | 0.25%10.35B | 6.57%5.3B | 15.02%10.32B | 18.91%4.98B | 1.37%8.97B | -0.48%4.18B | -5.91%8.85B |
Operating income | 16.75%6.11B | -0.30%10.32B | -1.23%5.24B | 0.25%10.35B | 6.57%5.3B | 15.02%10.32B | 18.91%4.98B | 1.37%8.97B | -0.48%4.18B | -5.91%8.85B |
Cost of sales | -89.95%-2.68B | 5.40%-2.93B | 11.36%-1.41B | -4.88%-3.09B | -18.51%-1.59B | -18.38%-2.95B | -17.67%-1.35B | -5.37%-2.49B | -15.81%-1.14B | 8.55%-2.37B |
Operating expenses | -89.95%-2.68B | 5.40%-2.93B | 11.36%-1.41B | -4.88%-3.09B | -18.51%-1.59B | -18.38%-2.95B | -17.67%-1.35B | -5.37%-2.49B | -15.81%-1.14B | 8.55%-2.37B |
Gross profit | -10.30%3.43B | 1.88%7.39B | 3.13%3.82B | -1.60%7.25B | 2.15%3.71B | 13.73%7.37B | 19.37%3.63B | -0.09%6.48B | -5.47%3.04B | -4.91%6.49B |
Administrative expenses | -4.92%-341M | -0.15%-651M | -6.21%-325M | -9.80%-650M | -12.09%-306M | -11.49%-592M | 6.51%-273M | 10.46%-531M | 7.89%-292M | 6.91%-593M |
Revaluation surplus | -352.59%-634M | 97.39%-9M | 213.57%251M | -175.00%-345M | -135.76%-221M | 106.90%460M | 113.31%618M | -175.75%-6.66B | -422.81%-4.64B | 110.96%8.8B |
-Changes in the fair value of investment property | -352.59%-634M | 97.39%-9M | 213.57%251M | -175.00%-345M | -135.76%-221M | 106.90%460M | 113.31%618M | -175.75%-6.66B | -422.81%-4.64B | 110.96%8.8B |
Special items of operating profit | 15.00%23M | 41.18%24M | 66.67%20M | -69.09%17M | -61.29%12M | 10.00%55M | 24.00%31M | 455.56%50M | 525.00%25M | -90.32%9M |
Operating profit | -34.27%2.48B | 7.62%6.75B | 18.07%3.77B | -13.97%6.28B | -20.29%3.19B | 1,198.49%7.29B | 314.45%4.01B | -104.52%-664M | -143.02%-1.87B | 40.70%14.7B |
Financing income | -33.33%26M | 12.70%71M | 30.00%39M | -13.70%63M | -31.82%30M | 15.87%73M | 41.94%44M | -56.85%63M | -67.71%31M | -67.19%146M |
Financing cost | -52.17%-455M | -35.16%-692M | -17.72%-299M | -5.13%-512M | -12.39%-254M | -179.89%-487M | -326.42%-226M | -278.26%-174M | -562.50%-53M | 95.70%-46M |
Share of profit from joint venture company | -5.00%19M | 50.00%36M | 81.82%20M | 200.00%24M | --11M | 109.09%8M | ---- | -1,077.78%-88M | -200.00%-38M | -90.72%9M |
Earning before tax | -41.42%2.07B | 5.44%6.17B | 18.46%3.53B | -15.07%5.85B | -22.07%2.98B | 898.15%6.89B | 298.34%3.82B | -105.83%-863M | -143.15%-1.93B | 49.27%14.81B |
Tax | 8.65%-729M | -8.19%-1.57B | -10.37%-798M | 30.24%-1.45B | 31.34%-723M | -74.60%-2.08B | -153.73%-1.05B | 76.18%-1.19B | 40.54%-415M | -294.72%-5.01B |
After-tax profit from continuing operations | -50.99%1.34B | 4.53%4.6B | 21.05%2.73B | -8.49%4.4B | -18.55%2.26B | 333.71%4.81B | 218.27%2.77B | -120.98%-2.06B | -162.15%-2.34B | 13.27%9.8B |
Earning after tax | -50.99%1.34B | 4.53%4.6B | 21.05%2.73B | -8.49%4.4B | -18.55%2.26B | 333.71%4.81B | 218.27%2.77B | -120.98%-2.06B | -162.15%-2.34B | 13.27%9.8B |
Minority profit | -17.75%278M | 11.59%626M | 9.39%338M | -40.13%561M | -42.35%309M | 81.94%937M | 176.29%536M | -85.80%515M | -23.62%194M | 532.06%3.63B |
Profit attributable to shareholders | -55.68%1.06B | 3.49%3.97B | 22.90%2.39B | -0.83%3.84B | -12.84%1.95B | 250.45%3.87B | 188.10%2.24B | -141.66%-2.57B | -172.16%-2.54B | -23.59%6.17B |
Basic earnings per share | -56.60%0.23 | 3.53%0.88 | 23.26%0.53 | -1.16%0.85 | -14.00%0.43 | 250.88%0.86 | 189.29%0.5 | -141.61%-0.57 | -171.79%-0.56 | -23.89%1.37 |
Diluted earnings per share | -56.60%0.23 | 3.53%0.88 | 23.26%0.53 | -1.16%0.85 | -14.00%0.43 | 250.88%0.86 | 189.29%0.5 | -141.61%-0.57 | -171.79%-0.56 | -23.89%1.37 |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.